Add to ORKGNatalizumab (NTZ) is a humanized anti-α4 integrin monoclonal antibody approved for relapsing–remitting multiple sclerosis (RRMS). Pivotal and post-marketing studies have proven its high and long-term efficacy
Natalizumab is the first monoclonal antibody approved for the treatment of relapsing multiple sclero...
Natalizumab, a highly specific alpha 4-integrin antagonist, is approved for treatment of patients wi...
Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system. It is charact...
Natalizumab (NTZ) is a humanized anti-α4 integrin monoclonal antibody approved for relapsing–remitti...
Natalizumab (Tysabri ® by Biogen Idec) is a human-ized monoclonal antibody indicated for the treatme...
Natalizumab is a humanized monoclonal antibody with a selective adhesion-molecule inhibitor effect, ...
In 1992, it was shown that monoclonal antibodies blocking alpha(4)-integrins prevent the development...
In the early 1990s, attention was drawn to the migration of immune cells into the central nervous sy...
Natalizumab is a monoclonal antibody directed against the \u3b14 chain of the very late activating a...
Copyright © 2015 Massimiliano Castellazzi et al.This is an open access article distributed under the...
In the early 1990s, attention was drawn to the migration of immune cells into the central nervous sy...
Natalizumab, a monoclonal antibody that blocks lymphocyte infiltration in the central nervous system...
Abstract Multiple sclerosis (MS) is a progressive immune-related disorder of the central nervous sys...
Natalizumab is approved for the treatment of patients with relapsing–remitting multiple sclerosis wh...
Natalizumab, a highly specific α4-integrin antagonist, is approved for treatment of patients with ac...
Natalizumab is the first monoclonal antibody approved for the treatment of relapsing multiple sclero...
Natalizumab, a highly specific alpha 4-integrin antagonist, is approved for treatment of patients wi...
Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system. It is charact...
Natalizumab (NTZ) is a humanized anti-α4 integrin monoclonal antibody approved for relapsing–remitti...
Natalizumab (Tysabri ® by Biogen Idec) is a human-ized monoclonal antibody indicated for the treatme...
Natalizumab is a humanized monoclonal antibody with a selective adhesion-molecule inhibitor effect, ...
In 1992, it was shown that monoclonal antibodies blocking alpha(4)-integrins prevent the development...
In the early 1990s, attention was drawn to the migration of immune cells into the central nervous sy...
Natalizumab is a monoclonal antibody directed against the \u3b14 chain of the very late activating a...
Copyright © 2015 Massimiliano Castellazzi et al.This is an open access article distributed under the...
In the early 1990s, attention was drawn to the migration of immune cells into the central nervous sy...
Natalizumab, a monoclonal antibody that blocks lymphocyte infiltration in the central nervous system...
Abstract Multiple sclerosis (MS) is a progressive immune-related disorder of the central nervous sys...
Natalizumab is approved for the treatment of patients with relapsing–remitting multiple sclerosis wh...
Natalizumab, a highly specific α4-integrin antagonist, is approved for treatment of patients with ac...
Natalizumab is the first monoclonal antibody approved for the treatment of relapsing multiple sclero...
Natalizumab, a highly specific alpha 4-integrin antagonist, is approved for treatment of patients wi...
Multiple sclerosis (MS) is a complex autoimmune disease of the central nervous system. It is charact...